États-Unis · Plateformes & données · MarketBeat

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Target Cut by Canaccord Genuity Group

Publié par MarketBeat · États-Unis il y a 26 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Canaccord Genuity Group reduced their target price on shares of Sagimet Biosciences from $56.00 to $50.00 and set a "buy" rating on the stock in a research report on Friday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Target Cut by Canaccord Genuity Group

Résumé détaillé

À lire aussi

Moving iMage Technologies GAAP EPS of $0.02, revenue of $6.1M

ADI Global Distribution: 3 Key Takeaways for Long-Term Investors

Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist

U-wifi Names Charlie Vogt to its Board of Directors

Soon We’ll Need an Advanced AI Chip … Just to Understand the Nvidia Drama

How the Jensen Huang affair changes the outlook for U.S.-China relations

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Target Cut by Canaccord Genuity Group

Résumé détaillé

Partager

À lire aussi

Moving iMage Technologies GAAP EPS of $0.02, revenue of $6.1M

ADI Global Distribution: 3 Key Takeaways for Long-Term Investors

Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist

U-wifi Names Charlie Vogt to its Board of Directors

Soon We’ll Need an Advanced AI Chip … Just to Understand the Nvidia Drama

How the Jensen Huang affair changes the outlook for U.S.-China relations